SUMMARY Seventy six peripheral T cell lymphomas were examined immunohistologically to test their reactivity with a panel of monoclonal antibodies against 11 T cell associated antigens (CD1-8, CD27, UCHL1, and the T cell antigen receptor). Sixty two (82%) lymphomas showed aberrant phenotypes, and four main categories were distinguished as follows: (i) lack of one or several pan-T cell antigens (49, 64% of the cases); (ii) loss of both the CD4 and CD8 antigens (11, 15% of the cases); (iii) coexpression of the CD4 and CD8 antigens (13, 17% of the cases); and (iv) expression ofthe CD I antigen (eight, 11 % of the cases). No correlation was seen between the occurrence of aberrant phenotypes and the histological subtype.
Two main groups of T cell tumours may be distinguished: immature (thymic) and peripheral (postthymic) T cell malignancies. The cells in the former group (T lymphoblastic lymphoma/leukaemia) express antigens characteristic of thymocytes' and are fairly homogeneous morphologically. In contrast, peripheral T cell lymphomas are heterogeneous and frequently present diagnostic problems with regard to their distinction from benign T cell infiltrates.
Recent studies have suggested that the expression of aberrant T cell phenotypes that is, those which differ from phenotypes seen on normal peripheral T cells mainly, if not exclusively, occurs in malignant T cell proliferations and thus may help to differentiate between benign and malignant disease.'2As T cell lymphomas are much less common than B cell malignancies few comprehensive studies have been made.
Material and methods
Biopsy samples from 76 peripheral T cell tumours were drawn from the frozen tissue banks at the laboratory of immunohistology, Aarhus (58 cases) and the department of pathology, Rigshospitalet (18 cases). Cases of mycosis fungoides and Sezary's syndrome were excluded, as these have been described in Accepted for publication 3 November 1988 detail previously.3 Anaplastic large cell lymphomas (Ki-l lymphomas) were also excluded and will be the subject of a separate report. In all cases routinely processed formalin fixed specimens were also available, and these were classified in accordance with the criteria described by Suchi et al. 4 The biopsy specimens were obtained fresh, The most common abnormality was (in descending order) a lack of CD7 (45%), CD27 (41%), TCR (25%), CD5 (24%), CD6 (17%), CD2 (15%), UCHL1 (11 %) and CD3 (9%).
Staining with antibody FIOI01 (against a conformational epitope of the TCR/CD3 complex) as well as CD3 was performed in 63 cases. Forty nine (78%) tumours were positive for FI01*01. All but one of these also expressed the CD3 antigen. Among the remaining 14 negative tumours, nine cases were positive for, and five were negative for, CD3.
SIMULTANEOUS LOSS OF THE CD4 AND CD8 ANTIGENS
A lack of both the helper and the suppressor cell associated CD4 and CD8 antigens was seen in 11 (15%) cases. Two of these showed no other immunophenotypic abnormalities. The remaining nine cases lacked either one or several pan-T cell antigens, including, in six cases, the TCR, and in four cases, the CD3 antigen. Three of the CD4 negative, CD8 group This is in keeping with the findings of our study in which 62 of 76 (82%) peripheral T cell lymphomas displayed aberrant phenotypes, as shown by examination with monoclonal antibodies against 11 T cell associated antigens. The prevalence of aberrant phenotypes among peripheral T cell lymphomas clearly depends on the number of antibodies used. Table 4 summarises the results ofthis and other similar reports. With the use of six or more antibodies, roughly two thirds of peripheral T cell lymphomas show aberrant phenotypes, but even with the same monoclonal antibodies some differences may be seen. This may result partly from differences in the types of lymphomas studied, which is why cases of mycosis fungoides and S&zary's syndrome were excluded from the present study but were included in the study of Borowitz et al and Nasu et al. ' 2 This could account for the somewhat lower incidence of aberrant phenotypes seen in these studies, as aberrant phenotypes occur relatively rarely in these conditions.3
In all studies a lack of pan-T cell antigens has been the most common immunophenotypic abnormality (table 4). In 22 (28%) of our cases only one pan-T cell antigen was absent. Similar results were reported by Picker et al 'and Borowitz et al,'0 whereas Nasu et al 12 reported loss of one pan-T cell antigen in 50% and Weiss et al " in 18% of peripheral T cell lymphomas. Hastrup, RalJkiaer, Pallesen In most studies the most common abnormality was an absence of CD7, followed by an absence of CD5.
Picker et al 9 used the monoclonal antibody fl-Fl (against a framework epitope of the TCR ,B chain) in their survey ofT lineage lymphomas and reported that expression of this epitope was independent of CD3 in one third of 33 peripheral T cell lymphomas. With the use of monoclonal FI 01*0 (against a conformational epitope of the TCR/CD3 complex,9 we found that this antigen is coexpressed with CD3 in 48 of 63 lymphomas. Five (8%) cases lacked both antigens, and the antigens were expressed independently ofeach other in 10 (16%) cases. In all but one of these the FIOI10 antigen was lost. This suggests that monoclonal antibody FlOI01 can help detect aberrant phenotypes.
The phenotype CD4 -/CD8 -/TCR -is displayed by fetal thymocytes and also by a minor fraction of adult cortical thymocytes and peripheral T cells.20 Among 11 lymphomas with simultaneous loss of the CD4 and CD8 antigens, eight cases were examined for expression of both CD3 and the TCR. Six of these were TCR negative and half of them also lacked CD3.
In contrast to the findings of Picker et al and others (table 4) , who observed coexpression of the CD4 and CD8 antigens only rarely, this phenotype was expressed by 17% of the present cases. Similar results were reported by Borowitz et al"' and Jack et al '7 and do not support the view that coexpression of CD4 and CD8 is indicative of lymphoblastic lymphomas.
Eleven per cent of our peripheral T cell lymphomas expressed the CDI antigen; this antigen has been identified only rarely in other studies.' '8 The morphology of the CD1 positive lymphomas varied, but none resembled lymphoblastic lymphoma.
It is concluded that the demonstration ofaberrant T cell phenotypes is a useful supplement to traditional histological methods for distinguishing between benign and malignant T cell infiltrates. It is recommended that the panel of monoclonal antibodies against T cell differentiation antigens should be fairly large, as apparently any antigen may be lost in the process of malignant transformation.
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